These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 16469504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional control of regulatory T cells and cancer immunotherapy.
    Wang RF.
    Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF, Miyahara Y, Wang HY.
    Oncogene; 2008 Jan 07; 27(2):181-9. PubMed ID: 18176599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulatory T cells and toll-like receptors in cancer therapy.
    Wang RF.
    Cancer Res; 2006 May 15; 66(10):4987-90. PubMed ID: 16707417
    [Abstract] [Full Text] [Related]

  • 9. Regulatory T cells and innate immune regulation in tumor immunity.
    Wang RF.
    Springer Semin Immunopathol; 2006 Aug 15; 28(1):17-23. PubMed ID: 16838179
    [Abstract] [Full Text] [Related]

  • 10. Toll-like receptors on regulatory T cells: expanding immune regulation.
    Sutmuller RP, Morgan ME, Netea MG, Grauer O, Adema GJ.
    Trends Immunol; 2006 Aug 15; 27(8):387-93. PubMed ID: 16814607
    [Abstract] [Full Text] [Related]

  • 11. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H, Marshall NA, Mills KH.
    Oncogene; 2008 Jan 07; 27(2):168-80. PubMed ID: 18176598
    [Abstract] [Full Text] [Related]

  • 12. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF.
    Clin Cancer Res; 2007 Dec 01; 13(23):6947-58. PubMed ID: 18056169
    [Abstract] [Full Text] [Related]

  • 13. Control of NK cell functions by CD4+CD25+ regulatory T cells.
    Ralainirina N, Poli A, Michel T, Poos L, Andrès E, Hentges F, Zimmer J.
    J Leukoc Biol; 2007 Jan 01; 81(1):144-53. PubMed ID: 16959895
    [Abstract] [Full Text] [Related]

  • 14. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
    Masteller EL, Tang Q, Bluestone JA.
    Semin Immunol; 2006 Apr 01; 18(2):103-10. PubMed ID: 16458533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH, Madireddi S, Sharma R, Yolcu ES, Shirwan H.
    Curr Opin Investig Drugs; 2007 Dec 01; 8(12):1002-8. PubMed ID: 18058571
    [Abstract] [Full Text] [Related]

  • 17. Regulatory T cells and systemic lupus erythematosus.
    Mudd PA, Teague BN, Farris AD.
    Scand J Immunol; 2006 Sep 01; 64(3):211-8. PubMed ID: 16918689
    [Abstract] [Full Text] [Related]

  • 18. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE, Xu M, Koski GK, Czerniecki BJ.
    Oncogene; 2008 Jan 07; 27(2):200-7. PubMed ID: 18176601
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H.
    Oncogene; 2008 Jan 07; 27(2):218-24. PubMed ID: 18176603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.